Pasar al contenido principal

DESCIFRANDO LA PATOGENESIS DEL SINDROME DE DRAVET: DEL GENOMA A LA FUNCION NEURONAL MEDIANTE EL USO DE ORGANOIDES CEREBRALES

PID2021-128208NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Variability vs. phenotype: Multimodal analysis of Dravet syndrome brain organoids powered by deep learning

  • Turpin-Moreno, Isabel
  • Modrego, Adriana
  • Martí-Sarrias, Andrea
  • García-González, Laura
  • Ortega-Gasco, Alba
  • Haeb, Anna-Christina
  • Pareja, Ruth
  • Soriano, Jordi
  • Ruiz, Núria
  • Peñuelas-Haro, Irene
  • Espinet, Elisa
  • Navarro, Arcadi
  • Tornero, Daniel
  • Lao, Oscar
  • Acosta, Sandra
Dravet syndrome (DS) is a developmental epileptic encephalopathy (DEE) driven by pathogenic variants in the SCN1A gene. Brain organoids (BOs) have emerged as reliable models for neurodevelopmental genetic disorders, reproducing human brain developmental milestones and rising as a promising drug testing tool. Here, we determined the underlying molecular DS pathophysiology affecting neuronal connectivity, revealing an early onset excitatory-inhibitory imbalance in maturing DS organoid circuitry. However, neuronal circuitry modeling in BOs remains hampered by the notorious inter- and intra-organoid variability. Thus, leveraging deep learning (DL), we developed ImPheNet, a predictive tool grounded in BO live imaging datasets, to overcome the limitations of the intrinsic BOs variability. ImPheNet accurately classified healthy and DS phenotypes at early onset stages, revealing differences between genotypes and upon antiseizure drug exposure. Altogether, our DL-predictive live imaging strategy, ImPheNet, emerges as a powerful tool to accelerate DEEs research and advance toward treatment discovery in a time- and cost-efficient manner., This project has been funded by Caixa Impulse (CXI20-0002) to S.A. and O.L., and AGAUR Llavor (2021) to S.A. J.S. and S.A. acknowledge support from grants PID2021-128208NB-100 and PID2022-137713NB-C22, respectively, funded by MCIU/AEI/10.13039/501100011033 and by ERDF/EU. D.T. acknowledges support from grant CNS2023-143862, funded by MCIN/AEI/10.13039/501100011033 and Next Generation EU/PRTR. D.T. and J.S. also acknowledge Generalitat de Catalunya under grants 2021SGR01086 and 2021-SGR-00450, respectively. This work has received funding from the European Union's Horizon 2020 research and innovation program under the grant agreement NeuChiP No. 964877 (A.-C.H, J.S., and D.T.). E.E. is funded by a Ramon y Cajal Fellowship (MICINN)., Peer reviewed